Henry Wolff

Henry Wolff

Direttore/Membro del Consiglio presso CALITHERA BIOSCIENCES, INC.
77 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Henry Ward Wolff is an Independent Director at Calithera Biosciences, Inc. He previously served as an Independent Director at MAP Pharmaceuticals LLC from 2008 to 2013, Sunesis Pharmaceuticals, Inc. from 2018 to 2021, and Portola Pharmaceuticals LLC from 2007 to 2020.
He was also an Executive Director at Russell Reynolds Associates, Inc. and Russell Reynolds Associates, Inc. (Germany) from 1985 to 1992.
Additionally, he held the position of Chief Financial Officer at Premenos Technology Corp.
from 1992 to 1998, Nuvelo, Inc. from 2006 to 2007, Abgenix, Inc. from 2004 to 2006, and DoubleTwist, Inc. from 1998 to 2002.
He was the Chief Financial Officer at QuantumShift, Inc. from 2002 to 2003.
Prior to that, he worked as a Senior Audit Manager at Pricewaterhouse LLP.
From 2007 to 2017, he served as the Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. Mr. Wolff obtained his undergraduate degree from the University of California, Berkeley and holds an MBA from Harvard Business School.

Posizioni attive di Henry Wolff

SocietàPosizioneInizio
CALITHERA BIOSCIENCES, INC. Direttore/Membro del Consiglio 02/12/2014

Precedenti posizioni note di Henry Wolff

SocietàPosizioneFine
VIRACTA THERAPEUTICS, INC. Direttore/Membro del Consiglio 24/02/2021
PORTOLA PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 01/01/2020
SANGAMO THERAPEUTICS, INC. Direttore Finanziario/CFO 01/03/2017
Direttore/Membro del Consiglio 01/03/2013
Direttore Finanziario/CFO 14/08/2007
Vedi nel dettaglio l'esperienza di Henry Wolff

Formazione di Henry Wolff

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

65

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private15

Communications

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Health Technology

Commercial Services

Consumer Services

  1. Mercati
  2. Insiders
  3. Henry Wolff
-40%: Proroga eccezionale
g
:
:
ENTRA ORA